Organisation paid for research Program year 2022 Source: CMS Open Payments

Alpha Neurology PC

Neither a doctor nor a teaching hospital

Research payments

$23,435

8 payments

Through program year 2022, Alpha Neurology PC is reported as receiving $23,435 in research payments, across 8 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$1,449	1
2021	Research	$4,631	1
2020	Research	$15,369	3
2019	Research	$1,986	3

Breakdown

Who paid Research payments · program years 2019–2022

Novartis Pharmaceuticals Corporation $17,067 3 payments
Mallinckrodt Hospital Products Inc. $3,858 2 payments
Genentech, Inc. $1,449 1 payment
Biogen, Inc. $1,061 2 payments

Studies the money was for Research payments · program years 2019–2022

Long Term Prospective Multinational Parallel Cohort Study Monitoring Safety in Patients With Multiple Sclerosis Newly Started With Fingolimod Once Daily Or Treated With Another Approved Disease Modifying Therapy $17,067 3 payments
Mallinckrodt Acthar Registry $3,858 2 payments
Ocrelizumab Vaccination Study $1,449 1 payment
Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants $547 1 payment
Plegridy Observational Program $514 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.